Sandbox:Amd: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 43: | Line 43: | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Other | | align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ||
|- | |- | ||
!Increased intake of fluid | !style="padding: 5px 5px; background: #DCDCDC;" align="center" |Increased intake of fluid | ||
! | ! | ||
![[Psychogenic polydipsia]] | !style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Psychogenic polydipsia]] | ||
! | ! | ||
! | ! | ||
Line 64: | Line 64: | ||
! | ! | ||
|- | |- | ||
! rowspan="4" |Increased solute excretion | ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Increased solute excretion | ||
! rowspan="2" |Osmotic causes | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Osmotic causes | ||
![[Diabetes mellitus]] | !style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus]] | ||
! | ! | ||
! | ! | ||
Line 85: | Line 85: | ||
! | ! | ||
|- | |- | ||
![[Mannitol]] | !style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Mannitol]] | ||
! | ! | ||
! | ! | ||
Line 104: | Line 104: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |Salt loss | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" ||Salt loss | ||
![[Diuretics]] | !style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diuretics]] | ||
! | ! | ||
! | ! | ||
Line 124: | Line 124: | ||
! | ! | ||
|- | |- | ||
![[Cerebral salt-wasting syndrome]] | !style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cerebral salt-wasting syndrome]] | ||
! | ! | ||
! | ! | ||
Line 143: | Line 143: | ||
! | ! | ||
|- | |- | ||
!Impaired urinary concentration | !style="padding: 5px 5px; background: #DCDCDC;" align="center" |Impaired urinary concentration | ||
! | !style="padding: 5px 5px; background: #DCDCDC;" align="center" | | ||
! | ! | ||
! | ! |
Revision as of 17:33, 7 May 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Differential diagnosis
Abbreviations:
POLYURIA
Mechanism | Etiology | Clinical manifestations | Paraclinical findings | Comments | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms and signs | Lab findings/Urine exam | Imaging | |||||||||||||||||
Fatigue/
Lethargy |
Thirst | Dizziness/
Confusion |
Weight loss | Hematuria | Dysuria | Proteinuria | Edema | Urine
osmolarity |
CT | Other | |||||||||
Increased intake of fluid | Psychogenic polydipsia | – | – | + | |||||||||||||||
Increased solute excretion | Osmotic causes | Diabetes mellitus | + | + | ± | ||||||||||||||
Mannitol | |||||||||||||||||||
rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Salt loss | Diuretics | |||||||||||||||||
Cerebral salt-wasting syndrome | |||||||||||||||||||
Impaired urinary concentration |
Differential diagnosis
Abbreviations: AP= Anteroposterior, CXR= Chest X-ray, CT= Computed tomography, ABG= Arterial blood gas, V/Q= Ventilation/perfusion scan , EKG= Electrocardiogram, COPD= Chronic obstructive pulmonary disease, BNP= Brain natriuretic peptide, DVT= Deep vein thrombosis, HRCT= High Resolution CT, IgE= Immunoglobulin E
|
- ↑ Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
- ↑ Khurshid I, Downie GH (2002). "Pulmonary arteriovenous malformation". Postgrad Med J. 78 (918): 191–7. PMC 1742331. PMID 11930021.
- ↑ Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). "Massive spontaneous hemothorax during the immediate postpartum period". Tex Heart Inst J. 36 (3): 247–9. PMC 2696501. PMID 19568398.
- ↑ Chanatry BJ (1992). "Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy". Anesth. Analg. 74 (4): 613–5. PMID 1554132.